Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: An in vitro model to study chondrodysplasias

FEBS Letters

Volumn 581, Issue 14, 2007, Pages 2593-2598

  Benoist Lasselin, Catherine ^a   Gibbs, Linda ^a   Heuertz, Solange ^a   Odent, Thierry ^a   Munnich, Arnold ^a   Legeai Mallet, Laurence ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Chondrodysplasias; FGFR3 mutations; Human immortalized chondrocytes

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 3; STAT PROTEIN;

ARTICLE; CARTILAGE CELL; CELL FUNCTION; CHONDRODYSPLASIA; CONTROLLED STUDY; HETEROZYGOSITY; HUMAN; HUMAN CELL; IN VITRO STUDY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CELLS, CULTURED; CHONDROCYTES; COLLAGEN TYPE II; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION; HETEROZYGOTE; HIGH MOBILITY GROUP PROTEINS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; OSTEOCHONDRODYSPLASIAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TRANSCRIPTION FACTORS;

EID: 34249715395     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.04.079     Document Type: Article

References (30)

1. Rousseau F., Bonaventure J., Legeai-Mallet L., Pelet A., Rozet J.M., Maroteaux P., Le Merrer M., and Munnich A. Mutations in the gene encoding fibroblast growth factor receptor 3 in achondroplasia. Nature 371 (1994) 252-254
2. Shiang R., Thompson L.M., Zhu Y.Z., Church D.M., Fielder T.J., Bocian M., Winokur S.T., and Wasmuth J.J. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 78 (1994) 335-342
3. Bellus G.A., McIntosh I., Smith E.A., Aylesworth A.S., Kaitila I., Horton W.A., Greenhaw G.A., Hecht J.T., and Francomano C.A. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat. Genet. 10 (1995) 357-359
4. Rousseau F., Saugier P., Le Merrer M., Munnich A., Delezoide A.L., Maroteaux P., Bonaventure J., Narcy F., and Sanak M. Stop codon FGFR3 mutations in thanatophoric dwarfism type 1. Nat. Genet. 10 (1995) 11-12
5. Rousseau F., El Ghouzzi V., Delezoide A.L., Legeai-Mallet L., LeMerrer M., Munnich A., and Bonaventure J. FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TDI). Hum. Mol. Genet. 5 (1996) 509-512
6. Tavormina P.L., Bellus G.A., Webster M., Bamshad M.J., Fraley A.E., McIntosh I., Szabo J., Jiang W., Jabs W.E., Wilcox W.R., Wasmuth J.J., Donoghue D.J., Thompson L.M., and Francomano C.A. A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. Am. J. Hum. Genet. 64 (1999) 722-731
7. Webster M., and Donoghue D.J. Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15 (1996) 520-527
8. Naski M.C., Wang Q., Xu J., and Ornitz D. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat. Genet. 13 (1996) 233-237
9. Legeai-Mallet L., Benoist-Lasselin C., Delezoide A.L., Munnich A., and Bonaventure J. Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J. Biol. Chem. 273 21 (1998) 13007-13014
10. Legeai-Mallet L., Benoist-Lasselin C., Munnich A., and Bonaventure J. Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. Bone 34 (2004) 26-36
11. Nowroozi N., Raffioni S., Wang T., Apostol B.L., Bradshaw R.A., and Thompson L.M. Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells. Hum. Mol. Genet. 14 (2005) 1529-1538
12. Raucci A., Laplantine E., Mansukhani A., and Basilico C. Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J. Biol. Chem. 279 (2004) 1747-1756
13. Shani M., Ambrosetti D.C., Mansukhani A., and Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 13 (1999) 1361-1368
14. Murakami S., Balmes G., McKinney S., Zhang Z., Givol D., and de Crombrugghe B. Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev. 18 (2003) 290-305
15. Su W.C., Kitagawa M.X., Xue N., Xie B., Garofalo S., Cho J., Deng C., Horton W.A., and Fu X.Y. Activation of Stat1 by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism. Nature 386 (1997) 288-292
16. Heuertz S., Le Merrer M., Zabel B., Wright M., Legeai-Mallet L., Cormier-Daire V., Gibbs L., and Bonaventure J. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur. J. Hum. Genet. 14 (2006) 1240-1247
17. Robbins J.R., Thomas B., Tan L., Choy B., Arbiser J.L., Berenbaum F., and Goldring M.B. Immortalized human adult articular chondrocytes maintain cartilage-specific phenotype and responses to interleukin-1beta. Arthritis Rheum. 43 (2000) 2189-2201
18. Tare R.S., Howard D., Pound J.C., Roach H.I., and Oreffo R.O. Tissue engineering strategies for cartilage generation - micromass and three dimensional cultures using human chondrocytes and a continuous cell line. Biochem. Bio. Res. Commun. 333 (2005) 609-621
19. Bi W., Deng J.M., Zhang Z., Behringer R.R., and de Crombrugghe B. Sox9 is required for cartilage formation. Nat. Genet. 22 (1999) 85-89
20. Lefebvre V., and de Crombrugghe B. Toward understanding SOX9 function in chondrocyte differentiation. Matrix Biol. 16 (1998) 529-540
21. Li C., Chen L., Iwata T., Kitagawa M., Fu X.Y., and Deng C.X. A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. Hum. Mol. Genet. 8 (1999) 35-44
22. Raffioni S., Zhu Y.Z., Bradshaw R.A., and Thompson L.M. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC12 cells. A model for the control of receptor tyrosine kinase activation. J. Biol. Chem. 273 (1998) 35250-35259
23. Lievens P.M.J., and Liboi E. The thanatophoric dysplasia type II mutation hampers complete maturation of fibroblast growth factor receptor 3 (FGFR3), which activates signal transducer and activator of transcription 1 (STAT1) from the endoplasmic reticulum. J. Biol. Chem. 278 (2003) 17344-17349
24. Lievens P.M.J., Mutinelli C., Baynes D., and Liboi E. The kinase activity of fibroblast growth factor receptor 3 with activation loop mutations affects receptor trafficking and signaling. J. Biol. Chem. 278 (2004) 43254-43260
25. Dailey L., laplantine E., Priore R., and Basilico C. A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J. Cell. Biol. 161 (2003) 1053-1066
26. Mallein-Gerin F., and Olsen B.R. Expression of simian virus 40 large T (tumor) oncogene in mouse chondrocytes induces cell proliferation without loss of the differentiated phenotype. Proc. Natl. Acad. Sci. USA 90 (1993) 3289-3293
27. Horton W., Cleveland J., Rapp U., Nemuth G., Bolander M., Doege K., Yamada Y., and Hassell J.R. An established rat cell line expressing chondrocyte properties. Exp. Cell. Res. 178 (1988) 457-468
28. Thenet S., Benya P.D., Demignot S., Feunteun J., and Adolphe M. SV40-immortalization of rabbit articular chondrocytes: alteration of differentiated functions. J. Cell. Physiol. 150 (1992) 158-167
29. Finger F., Schörle C., Zien A., Gebhard P., Goldring M.B., and Aigner T. Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum. 48 (2003) 3395-3403
30. Finger F., Schorle C., Soder S., Zien A., Goldring M.B., and Aigner T. Phenotypic characterization of human chondrocyte cell line C-20/A4: a comparison between monolayer and alginate suspension culture. Cells Tissues Organs 178 (2004) 65-77